NEUTROPHIL CHEMOTACTIC FACTOR AND ALCOHOLIC HEPATITIS
中性粒细胞趋化因子与酒精性肝炎
基本信息
- 批准号:2682972
- 负责人:
- 金额:$ 13.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-04-01 至 1999-03-31
- 项目状态:已结题
- 来源:
- 关键词:acetaldehyde alcoholic hepatitis chemical structure function chemoattractants coenzyme A cytochrome oxidase dosage eicosanoid metabolism enzyme inhibitors ethanol gas chromatography mass spectrometry high performance liquid chromatography laboratory rat leukotrienes liver metabolism liver pharmacology mass spectrometry neutrophil organelles oxidation prostaglandin F
项目摘要
The liver is a major organ for the metabolism of ethanol as well as
leukotrienes, prostaglandins, and thromboxanes. Leukotriene B4 is a
metabolite of arachidonic acid known to be produced by inflammatory cells
such as the polymorphonuclear leukocyte (neutrophil) and the hepatocyte
has a specific uptake system to remove leukotrienes and other eicosanoids
from the circulation. Interest in LTB4 stems from its potent biological
activity as a chemotactic factor for the neutrophil and its role in vivo
causing accumulation and activation of neutrophils at the site of
inflammation. The hepatocyte metabolizes LTB4 into inactive compounds;
thus the liver plays a central role in the termination of biological
activity of LTB4. Ethanol has been found to alter the metabolism of LTB4
and furthermore the observed metabolites retain significant biological
activity. We have suggested that the failure of the hepatocyte to
inactivate LTB4 by metabolism may generate a chemotactic gradient with
which neutrophils can be attracted. We have suggested that if LTB4 is
synthesized at some distal site to the liver when ethanol is ingested by
humans, hepatocytes will fail to inactivate the accumulating LTB4,
recruiting neutrophils to invade the hepatocyte. This hypothesis has been
termed by us as the remote-site hypothesis and may play a role in
alcoholic hepatitis. With this hypothesis in mind it is therefore of
interest to understand the detailed biochemistry of LTB4 metabolism in
the hepatocyte when ethanol is present.
Even at relatively low doses (10-50 mM) ethanol metabolism in the
hepatocyte can itself involve numerous enzymes relevant to eicosanoid
metabolism, including alcohol dehydrogenase, peroxisomal catalase,
microsomal cytochrome P-45O, and alter important cofactors such as the
NADH/NAD+ ratio. The product of ethanol metabolism, acetaldehyde, can
also have effects on various enzymes, in particular an interaction with
catalase and H2O2, a product of peroxisomal beta-oxidation. Other
metabolites of arachidonic acid (eicosanoids such as prostaglandins and
thromboxanes) are also metabolized by the liver and nothing is known
about the effects of ethanol on the metabolic fate of these compounds.
Since eicosanoids have a myriad of biological properties, an effect of
ethanol within the hepatocyte, or in other cells that metabolize
eicosanoids, may be manifested by altered cellular responses to these
lipid mediators. An understanding of how metabolism of lipid mediators
of cell activation are altered by ethanol and acetaldehyde may provide
insight into the biochemical effects of ethanol which at present are not
fully understood.
肝脏是乙醇代谢的主要器官
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of novel metabolites of prostaglandin E2 formed by isolated rat hepatocytes.
- DOI:10.1006/abbi.1997.9921
- 发表时间:1997-04
- 期刊:
- 影响因子:3.9
- 作者:J. Hankin;P. Wheelan;R. Murphy
- 通讯作者:J. Hankin;P. Wheelan;R. Murphy
The effects of ethanol and acetaldehyde on the metabolism of prostaglandin E2 and leukotriene B4 in isolated rat hepatocytes.
乙醇和乙醛对离体大鼠肝细胞前列腺素E2和白三烯B4代谢的影响。
- DOI:
- 发表时间:1998
- 期刊:
- 影响因子:0
- 作者:Hankin,JA;Clay,CE;Murphy,RC
- 通讯作者:Murphy,RC
Quantitation of 5-lipoxygenase products by electrospray mass spectrometry: effect of ethanol on zymosan-stimulated production of 5-lipoxygenase products by human neutrophils.
通过电喷雾质谱法定量 5-脂氧合酶产物:乙醇对酵母聚糖刺激的人中性粒细胞产生 5-脂氧合酶产物的影响。
- DOI:10.1006/abio.1996.9885
- 发表时间:1997
- 期刊:
- 影响因子:0
- 作者:Wheelan,P;Murphy,RC
- 通讯作者:Murphy,RC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT Carl MURPHY其他文献
ROBERT Carl MURPHY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT Carl MURPHY', 18)}}的其他基金
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry
通过 MALDI/离子淌度质谱法进行高通量脂质组学分析
- 批准号:
8687651 - 财政年份:2012
- 资助金额:
$ 13.37万 - 项目类别:
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry
通过 MALDI/离子淌度质谱法进行高通量脂质组学分析
- 批准号:
8545850 - 财政年份:2012
- 资助金额:
$ 13.37万 - 项目类别:
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry
通过 MALDI/离子淌度质谱法进行高通量脂质组学分析
- 批准号:
8415669 - 财政年份:2012
- 资助金额:
$ 13.37万 - 项目类别:
Bioactive lipid mediators and reactive oxygen species
生物活性脂质介质和活性氧
- 批准号:
7142874 - 财政年份:2005
- 资助金额:
$ 13.37万 - 项目类别:
BRIDGE C--LC/Mass Spectrometric Analysis/Neutral Lipids
BRIDGE C--LC/质谱分析/中性脂质
- 批准号:
6802648 - 财政年份:2003
- 资助金额:
$ 13.37万 - 项目类别:
Isoeicosanoids& Biologically Active Oxidized Phospholipi
异二十烷酸
- 批准号:
6611191 - 财政年份:2002
- 资助金额:
$ 13.37万 - 项目类别:
EOSINOPHILS, EICOSANOID BIOSYNTHESIS AND METABOLISM
嗜酸性粒细胞、类二十烷酸生物合成和代谢
- 批准号:
6612400 - 财政年份:2002
- 资助金额:
$ 13.37万 - 项目类别:
EOSINOPHIL, EICOSANOID, BIOSYNTHESIS AND METABOLISM
嗜酸性粒细胞、类二十烷酸、生物合成和代谢
- 批准号:
6263126 - 财政年份:2001
- 资助金额:
$ 13.37万 - 项目类别:
相似海外基金
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 13.37万 - 项目类别:
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
- 批准号:
10527603 - 财政年份:2022
- 资助金额:
$ 13.37万 - 项目类别:
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
- 批准号:
10686094 - 财政年份:2022
- 资助金额:
$ 13.37万 - 项目类别:
An innovative non-thiazolidinedione pan-PPAR agonist therapeutic for Alcoholic Hepatitis
一种创新的非噻唑烷二酮类泛 PPAR 激动剂,用于治疗酒精性肝炎
- 批准号:
10482468 - 财政年份:2022
- 资助金额:
$ 13.37万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10298412 - 财政年份:2021
- 资助金额:
$ 13.37万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10494268 - 财政年份:2021
- 资助金额:
$ 13.37万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10617893 - 财政年份:2021
- 资助金额:
$ 13.37万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10646369 - 财政年份:2021
- 资助金额:
$ 13.37万 - 项目类别:
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
酒精性肝炎中中性粒细胞和胆管细胞之间的相互作用
- 批准号:
10874892 - 财政年份:2021
- 资助金额:
$ 13.37万 - 项目类别: